Carbapenems: Past, Present, and Future

By K. Papp-Wallace, A. Endimiani, M. Taracila, Robert A. Bonomo. Antimicrobial Agents and Chemotherapy, 2011

1,298 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Molecular Medicine, Pharmacology

View Paper: https://www.semanticscholar.org/paper/01a5f1a018c97835e5ca958c70fa4d231dd5642b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Medicine

1. F. Codjoe
2. E. Donkor
3. C. Giske
4. T. Strateva
5. S. Cosgrove

In Pharmacology

1. F. Codjoe
2. E. Donkor
3. T. Strateva

Citations in the corpus

• Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread (2019, background): “The emergence of carbapenem resistance is a major setback in the ability to effectively treat Gram-negative bacterial infections [20].”
• Carbapenem Resistance: A Review (2017, background): “According to [18], the mode of action of carbapenems remains uncertain.”